Home Cart 0 Sign in  
X

[ CAS No. 5900-58-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 5900-58-3
Chemical Structure| 5900-58-3
Chemical Structure| 5900-58-3
Structure of 5900-58-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 5900-58-3 ]

Related Doc. of [ 5900-58-3 ]

Alternatived Products of [ 5900-58-3 ]

Product Details of [ 5900-58-3 ]

CAS No. :5900-58-3 MDL No. :MFCD00017568
Formula : C8H8ClNO2 Boiling Point : -
Linear Structure Formula :- InChI Key :YPSSCICDVDOEAI-UHFFFAOYSA-N
M.W : 185.61 Pubchem ID :80001
Synonyms :

Calculated chemistry of [ 5900-58-3 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 47.14
TPSA : 52.32 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.09 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.99
Log Po/w (XLOGP3) : 3.3
Log Po/w (WLOGP) : 1.72
Log Po/w (MLOGP) : 1.91
Log Po/w (SILICOS-IT) : 1.61
Consensus Log Po/w : 2.11

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.31
Solubility : 0.0914 mg/ml ; 0.000492 mol/l
Class : Soluble
Log S (Ali) : -4.07
Solubility : 0.0156 mg/ml ; 0.0000843 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -2.73
Solubility : 0.344 mg/ml ; 0.00185 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.3

Safety of [ 5900-58-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 5900-58-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 5900-58-3 ]
  • Downstream synthetic route of [ 5900-58-3 ]

[ 5900-58-3 ] Synthesis Path-Upstream   1~30

  • 1
  • [ 5900-58-3 ]
  • [ 77287-34-4 ]
  • [ 31374-18-2 ]
YieldReaction ConditionsOperation in experiment
84.1% at 150℃; for 2 h; Examples 13 to 21:; The reaction and the post-treatment were carried out in the same manner as in Example 5, for which, however, the type of the anthranilic acid derivative was changed. The results are shown in Table 4.
Reference: [1] Patent: EP1997812, 2008, A1, . Location in patent: Page/Page column 8
[2] MedChemComm, 2014, vol. 5, # 9, p. 1290 - 1296
[3] Bioorganic Chemistry, 2018, vol. 80, p. 433 - 443
  • 2
  • [ 5900-58-3 ]
  • [ 2148-57-4 ]
Reference: [1] MedChemComm, 2014, vol. 5, # 9, p. 1290 - 1296
[2] Bioorganic Chemistry, 2018, vol. 80, p. 433 - 443
  • 3
  • [ 5900-58-3 ]
  • [ 1677-49-2 ]
Reference: [1] Journal of the American Chemical Society, 1946, vol. 68, p. 1285,1288
[2] Journal of the American Chemical Society, 1946, vol. 68, p. 1285,1288
  • 4
  • [ 5900-58-3 ]
  • [ 57-13-6 ]
  • [ 13165-35-0 ]
Reference: [1] Journal of Organic Chemistry, 1981, vol. 46, # 8, p. 1699 - 1702
  • 5
  • [ 5900-58-3 ]
  • [ 89-77-0 ]
Reference: [1] Patent: WO2018/144620, 2018, A1, . Location in patent: Paragraph 00426
  • 6
  • [ 67-56-1 ]
  • [ 6341-92-0 ]
  • [ 5900-58-3 ]
  • [ 89-77-0 ]
Reference: [1] Angewandte Chemie, 1981, vol. 93, # 10, p. 914 - 915
  • 7
  • [ 67-56-1 ]
  • [ 89-77-0 ]
  • [ 5900-58-3 ]
YieldReaction ConditionsOperation in experiment
83% at -5℃; for 4.5 h; Reflux; Industrial scale 17.1g of 4-chloro-2-aminobenzoic acid (0.1mol), 100mL of methanol was added to the reaction vessel, stirred to dissolve, cooled to -5 ~ 0 ,Slowly added dropwise 10mL thionyl chloride, dropwise addition, remove the ice bath, slowly warmed to room temperature, stirred 0.5h, the reaction was warmed to reflux, the reaction 4h, steamed added 70mL methanol, the next set of applications, the raffinate Add ice water, add sodium bicarbonate to neutral, filter, the filter cake was dissolved with 100mL dichloromethane, filtered to give unreacted 4-chloro-2-amino benzoic acid 1.8g, can be applied directly to the next ester The methylene chloride layer was dried over 5 g of anhydrous sodium sulfate, filtered and the solvent was distilled off to obtain 15.4 g of methyl 4-chloro-2-aminobenzoate (2) in a yield of 83percent.
82% at 0 - 5℃; for 24 h; Reflux A single-mouth bottle was charged with 10 g of 2-amino-4-chlorobenzoic acid, 150 ml of methanol, cooled to 0 to 5 ° C, and 10.4 g of thionyl chloride was added dropwise thereto.After the addition was completed, the temperature was refluxed for 24 hrs. It was cooled to room temperature and concentrated under reduced pressure to remove methanol.Add 100 ml of ethyl acetate, 100 ml of 5percent sodium carbonate solution, stir, let stand, separate the aqueous layer, and wash the organic layer with 100 ml of water.Dry over anhydrous sodium sulfate and concentrate under reduced pressureMethyl 2-amino-4-chlorobenzoate 8.9 g, yield 82percent.
62%
Stage #1: With hydrogenchloride In water for 12 h; Reflux
Stage #2: With sodium hydroxide In water
Methyl 2-amino-4-chlorobenzoate; To a mixture of 2-amino-4-chlorobenzoic acid (150 g, 0.88 mol) in MeOH (2.6 L) was added cone. HCl (0.5 L, 16.5 mol) and the reaction mixture was allowed to stir at reflux. After 12 h, the reaction mixture was allowed to cool to rt and was concentrated. Water (0.5 L) was added to the residue and the solution basified with 10percent aqueous NaOH. The resulting precipitate was filtered to give methyl 2-amino-4-chlorobenzoate (101 g, 62percent).
Reference: [1] Journal of Medicinal Chemistry, 1996, vol. 39, # 17, p. 3248 - 3255
[2] Patent: CN106243046, 2016, A, . Location in patent: Paragraph 0047; 0052; 0053; 0073; 0074
[3] Patent: CN107778229, 2018, A, . Location in patent: Paragraph 0021
[4] Patent: WO2010/65134, 2010, A1, . Location in patent: Page/Page column 60
[5] Journal of the Chemical Society, 1947, p. 808,811
[6] Journal fuer Praktische Chemie (Leipzig), 1929, vol. <2> 120, p. 69
[7] Journal of the American Chemical Society, 1923, vol. 45, p. 1028
[8] Chemistry of Heterocyclic Compounds, 2006, vol. 42, # 1, p. 64 - 69
[9] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 10, p. 5803 - 5814
[10] Journal of Medicinal Chemistry, 2013, vol. 56, # 21, p. 8332 - 8338
[11] Organic and Biomolecular Chemistry, 2015, vol. 13, # 47, p. 11486 - 11491
[12] Patent: CN105503668, 2016, A, . Location in patent: Paragraph 0021; 0023
[13] Advanced Synthesis and Catalysis, 2018, vol. 360, # 10, p. 1919 - 1925
  • 8
  • [ 89-77-0 ]
  • [ 18107-18-1 ]
  • [ 5900-58-3 ]
YieldReaction ConditionsOperation in experiment
93% at 0 - 20℃; Inert atmosphere First, into a 500-mL 3-necked round-bottom flask purged and maintained with an inert atmosphere of nitrogen, was placed methanol/DCM (150/100 mL), 2-amino-4-chlorobenzoic acid (10 g, 58.28 mmol, 1.00 equiv). This was followed by the addition of TMSCHN2 (30.7 mL, 1.05 equiv) dropwise with stirring at 0° C. The resulting solution was stirred overnight at room temperature. The resulting mixture was concentrated under vacuum. The resulting mixture was washed with 1×20 mL of n-hexane. This resulted in 10.1 g (93percent) of methyl 2-amino-4-chlorobenzoate as a yellow solid.
Reference: [1] Patent: US2015/366198, 2015, A1, . Location in patent: Paragraph 0146
  • 9
  • [ 42087-80-9 ]
  • [ 5900-58-3 ]
Reference: [1] Journal of Organic Chemistry, 2010, vol. 75, # 14, p. 4887 - 4890
[2] Bioorganic and Medicinal Chemistry, 1999, vol. 7, # 8, p. 1743 - 1754
  • 10
  • [ 77-76-9 ]
  • [ 89-77-0 ]
  • [ 5900-58-3 ]
Reference: [1] Tetrahedron, 2004, vol. 60, # 13, p. 3017 - 3035
[2] Tetrahedron Letters, 2001, vol. 42, # 45, p. 8029 - 8033
  • 11
  • [ 89-77-0 ]
  • [ 5900-58-3 ]
Reference: [1] Patent: US3949081, 1976, A,
[2] Patent: US3989689, 1976, A,
  • 12
  • [ 186581-53-3 ]
  • [ 89-77-0 ]
  • [ 5900-58-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 2, p. 738 - 743
  • 13
  • [ 6280-88-2 ]
  • [ 5900-58-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 1999, vol. 7, # 8, p. 1743 - 1754
[2] Journal of the American Chemical Society, 1923, vol. 45, p. 1028
  • 14
  • [ 34662-32-3 ]
  • [ 5900-58-3 ]
Reference: [1] Journal of the American Chemical Society, 1923, vol. 45, p. 1028
[2] Journal of the American Chemical Society, 1923, vol. 45, p. 1028
  • 15
  • [ 89-63-4 ]
  • [ 5900-58-3 ]
Reference: [1] Journal of the American Chemical Society, 1923, vol. 45, p. 1028
[2] Journal of the American Chemical Society, 1923, vol. 45, p. 1028
  • 16
  • [ 5900-59-4 ]
  • [ 5900-58-3 ]
Reference: [1] Journal of the American Chemical Society, 1923, vol. 45, p. 1028
  • 17
  • [ 89-59-8 ]
  • [ 5900-58-3 ]
Reference: [1] Journal of the American Chemical Society, 1946, vol. 68, p. 1285,1288
  • 18
  • [ 5900-55-0 ]
  • [ 5900-58-3 ]
Reference: [1] Journal of the American Chemical Society, 1946, vol. 68, p. 1285,1288
  • 19
  • [ 95-79-4 ]
  • [ 5900-58-3 ]
Reference: [1] Journal of the American Chemical Society, 1946, vol. 68, p. 1285,1288
  • 20
  • [ 67-56-1 ]
  • [ 5900-56-1 ]
  • [ 5900-58-3 ]
Reference: [1] Journal of the American Chemical Society, 1946, vol. 68, p. 1285,1288
  • 21
  • [ 717879-44-2 ]
  • [ 5900-58-3 ]
Reference: [1] ChemMedChem, 2017, vol. 12, # 3, p. 197 - 201
  • 22
  • [ 67-56-1 ]
  • [ 6341-92-0 ]
  • [ 5900-58-3 ]
  • [ 89-77-0 ]
Reference: [1] Angewandte Chemie, 1981, vol. 93, # 10, p. 914 - 915
  • 23
  • [ 5900-58-3 ]
  • [ 5900-59-4 ]
Reference: [1] Journal of Medicinal Chemistry, 1997, vol. 40, # 5, p. 754 - 765
[2] Journal of Medicinal Chemistry, 1997, vol. 40, # 25, p. 4053 - 4068
[3] Journal of the Chemical Society, 1948, p. 1713
  • 24
  • [ 5900-58-3 ]
  • [ 544-92-3 ]
  • [ 58331-97-8 ]
Reference: [1] Journal of Medicinal Chemistry, 1992, vol. 35, # 24, p. 4613 - 4627
  • 25
  • [ 5900-58-3 ]
  • [ 37585-16-3 ]
YieldReaction ConditionsOperation in experiment
69%
Stage #1: With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; for 2.16667 h;
Stage #2: With water; sodium sulfate In tetrahydrofuran at 0℃;
(2-Amino-4-chlorophenyl)methanol. Methyl 2-amino-4-chlorobenzoate (1.5 g, 8.08 mmol) in THF (15 mL) was dropwise added to the suspension of LAH (429 mg, 11.3 mmol) in THF (10 mL) under N2 at 0° C. over 10 min. The resulting mixture was stirred at room temperature for 2 hrs, then the reaction was quenched at 0° C. with saturated Na2SO4 (50 mL), extracted with Et2O (2.x.70 mL). The combined organic solutions were washed with brine (30 mL), dried on MgSO4, and concentrated on rotary vacuum to afford the expected product as a white solid (874 mg, 69percent yield); 1H NMR (400 MHz, MeOD) δ ppm 4.50 (s, 2H), 6.58 (dd, J=8.06, 2.01 Hz, 1H), 6.70 (d, J=2.01 Hz, 1H), 7.01 (d, J=8.06 Hz, 1H); Mass spec. 157.06 (MH+), Calc. for C7H8ClNO 157.03.
69%
Stage #1: With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; for 2.16667 h;
Stage #2: With water In tetrahydrofuran
(2-Amino-4-chlorophenyl)methanol; Methyl 2-amino-4-chlorobenzoate (1.5 g,8.08 mmol) in THF (15 mL) was dropwise added to the suspension of LAH(429 mg, 11.3 mmol) in THF (10 mL) under N2 at 0° C. over 10 min. The resulting mixture was stirred at room temperature for 2 hrs, then the reaction was quenched at 0° C. with saturated Na2SO4 (50 mL), extracted with Et2O (2.x.70 mL). The combined organic solutions were washed with brine (30 mL), dried on MgSO4, and concentrated on rotary vacuum to afford the expected product as a white solid (874 mg, 69percent yield); 1H NMR (400 MHz, MeOD) δ ppm 4.50 (s, 2 H), 6.58 (dd, J=8.06, 2.01 Hz, 1 H), 6.70 (d, J=2.01 Hz, 1 H), 7.01 (d, J=8.06 Hz, 1 H); Mass spec. 157.06 (MH+), Calc. for C7H8ClNO2 157.03.
Reference: [1] Patent: US2006/94707, 2006, A1, . Location in patent: Page/Page column 62
[2] Patent: US2007/259850, 2007, A1, . Location in patent: Page/Page column 96-97
  • 26
  • [ 5900-58-3 ]
  • [ 181765-85-5 ]
Reference: [1] Organic and Biomolecular Chemistry, 2017, vol. 15, # 45, p. 9680 - 9684
  • 27
  • [ 5900-58-3 ]
  • [ 85392-01-4 ]
Reference: [1] Journal of Heterocyclic Chemistry, 2004, vol. 41, # 3, p. 435 - 438
[2] Patent: US7115545, 2006, B1, . Location in patent: Page/Page column 2
[3] Patent: WO2015/138791, 2015, A1, . Location in patent: Page/Page column 128; 129
[4] Patent: CN105503668, 2016, A, . Location in patent: Paragraph 0021; 0023
[5] Patent: CN106243046, 2016, A,
  • 28
  • [ 5900-58-3 ]
  • [ 107-06-2 ]
  • [ 85392-01-4 ]
Reference: [1] Patent: US6583089, 2003, B1,
  • 29
  • [ 5900-58-3 ]
  • [ 199850-56-1 ]
YieldReaction ConditionsOperation in experiment
99% With iodine; silver sulfate In ethanol at 20℃; for 0.75 h; Methyl 2-amino-4-chloro-5-iodobenzoate; To a mixture of iodine (68 g, 0.27 mol) and silver sulfate (84 g, 0.27 mol) in absolute EtOH (2.5 L) was added methyl 2-amino-4-chlorobenzoate (50 g, 0.27 mol). The reaction mixture was allowed to stir at rt for 45 min. The reaction mixture was then filtered through a pad of Celite.(R). and the filtrate was concentrated. The residue was dissolved in EtOAc (2 L) and washed with saturated aqueous NaHCO3 (3 x 400 mL), water (3 x 400 mL), and brine. The organic solution was dried over Na2SO4, filtered, and concentrated to give methyl 2-amino-4-chloro-5-iodobenzoate (85 g, 99percent).
76% at 20℃; for 0.75 h; Methyl 2-amino-4-chloro-5-iodobenzoate To a mixture of I2 (6.8 g, 27.0 mmol) and Ag2SO4 (8.4 g, 27.0 mmol) in EtOH (250 mL), methyl 2-amino-4-chlorobenzoate (5.0 g, 27.0 mmol) was added and the resulting mixture was stirred at RT for 45 min. The solid was filtered off and washed with dichloromethane, and the filtrate was concentrated in vacuo. The residue was extracted with dichloromethane and washed with brine. The organic layer was dried over Na2SO4 and concentrated in vacuo to afford the desired product (6.4 g, 76percent yield) as a white solid. ESI-MS m/z: 311.9 [M + H]+.
55.6% With iodine; silver sulfate In ethanol Intermediate 2 : Methyl 2-amino-4-chloro-5-iodobenzoateTo a solution of methyl 2-amino-4-chlorobenzoate (Aldrich, 1 11 g, 600 mmol) and silver sulfate (187 g, 600 mmol) in ethanol (1000 mL) was added dropwise in 8 hours a solution of iodine (152 g, 600 mmol) in ethanol (2000 mL). The reaction mixture was stirred overnight then filtered through a celite plug. The filtrate was concentrated under reduced pressure and the residue was triturated in n-heptane. The resulting solid was filtered, washed with diisopropyl ether to give the title compound methyl 2-amino-4-chloro-5-iodobenzoate (103.76 g, 334 mmol, 55.6percent yield) as a white powder. LCMS: (M+H)+ = 312 ; Rt = 3.46 min.
Reference: [1] Journal of Labelled Compounds and Radiopharmaceuticals, 2003, vol. 46, # 10, p. 993 - 1000
[2] Chemical Communications, 2017, vol. 53, # 62, p. 8735 - 8738
[3] Patent: WO2010/65134, 2010, A1, . Location in patent: Page/Page column 60-61
[4] Patent: WO2015/54572, 2015, A1, . Location in patent: Page/Page column 261; 262
[5] Patent: WO2012/119978, 2012, A1, . Location in patent: Page/Page column 50
[6] Bioorganic and Medicinal Chemistry Letters, 2000, vol. 10, # 5, p. 443 - 447
[7] Bioorganic and Medicinal Chemistry Letters, 2000, vol. 10, # 15, p. 1723 - 1727
[8] Journal of Medicinal Chemistry, 2001, vol. 44, # 6, p. 917 - 922
[9] Patent: WO2004/18419, 2004, A2, . Location in patent: Page 266
[10] ChemMedChem, 2017, vol. 12, # 3, p. 197 - 201
  • 30
  • [ 5900-58-3 ]
  • [ 208465-21-8 ]
Reference: [1] Patent: CN106243046, 2016, A,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 5900-58-3 ]

Aryls

Chemical Structure| 294190-18-4

[ 294190-18-4 ]

Methyl 3-amino-5-chloro-2-methylbenzoate

Similarity: 0.95

Chemical Structure| 1619264-45-7

[ 1619264-45-7 ]

Methyl 2-amino-6-chlorobenzoate hydrochloride

Similarity: 0.93

Chemical Structure| 89-77-0

[ 89-77-0 ]

2-Amino-4-chlorobenzoic acid

Similarity: 0.92

Chemical Structure| 55150-07-7

[ 55150-07-7 ]

Methyl 5-chloro-2-(methylamino)benzoate

Similarity: 0.91

Chemical Structure| 21961-31-9

[ 21961-31-9 ]

Methyl 3-amino-5-chlorobenzoate

Similarity: 0.91

Chlorides

Chemical Structure| 294190-18-4

[ 294190-18-4 ]

Methyl 3-amino-5-chloro-2-methylbenzoate

Similarity: 0.95

Chemical Structure| 1619264-45-7

[ 1619264-45-7 ]

Methyl 2-amino-6-chlorobenzoate hydrochloride

Similarity: 0.93

Chemical Structure| 89-77-0

[ 89-77-0 ]

2-Amino-4-chlorobenzoic acid

Similarity: 0.92

Chemical Structure| 55150-07-7

[ 55150-07-7 ]

Methyl 5-chloro-2-(methylamino)benzoate

Similarity: 0.91

Chemical Structure| 21961-31-9

[ 21961-31-9 ]

Methyl 3-amino-5-chlorobenzoate

Similarity: 0.91

Esters

Chemical Structure| 294190-18-4

[ 294190-18-4 ]

Methyl 3-amino-5-chloro-2-methylbenzoate

Similarity: 0.95

Chemical Structure| 1619264-45-7

[ 1619264-45-7 ]

Methyl 2-amino-6-chlorobenzoate hydrochloride

Similarity: 0.93

Chemical Structure| 55150-07-7

[ 55150-07-7 ]

Methyl 5-chloro-2-(methylamino)benzoate

Similarity: 0.91

Chemical Structure| 21961-31-9

[ 21961-31-9 ]

Methyl 3-amino-5-chlorobenzoate

Similarity: 0.91

Chemical Structure| 172217-11-7

[ 172217-11-7 ]

Ethyl 2-amino-6-chlorobenzoate

Similarity: 0.90

Amines

Chemical Structure| 294190-18-4

[ 294190-18-4 ]

Methyl 3-amino-5-chloro-2-methylbenzoate

Similarity: 0.95

Chemical Structure| 1619264-45-7

[ 1619264-45-7 ]

Methyl 2-amino-6-chlorobenzoate hydrochloride

Similarity: 0.93

Chemical Structure| 89-77-0

[ 89-77-0 ]

2-Amino-4-chlorobenzoic acid

Similarity: 0.92

Chemical Structure| 55150-07-7

[ 55150-07-7 ]

Methyl 5-chloro-2-(methylamino)benzoate

Similarity: 0.91

Chemical Structure| 21961-31-9

[ 21961-31-9 ]

Methyl 3-amino-5-chlorobenzoate

Similarity: 0.91